Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Albemarle To Sell Portion Of Performance Catalysts Unit

Published 12/14/2017, 09:37 PM
Updated 07/09/2023, 06:31 AM

Albemarle Corporation (NYSE:ALB) entered into a definitive agreement to divest its polyolefin catalysts and components business to W.R. Grace & Co. in a cash deal valued at roughly $416 million. The deal, which is subject to regulatory approvals and other customary closing conditions, is expected to close during the first quarter of 2018.

Per the terms of the deal, the curatives and organometallics portions of the Performance Catalysts Solutions business will remain with Albemarle. Grace will assume the operations and lease at the Product Development Center in Baton Rouge, LA, and operations at the Yeosu site in South Korea.

Per Albemarle, this move demonstrates its continued commitment toward portfolio management in the best interest of shareholders and employees. Grace is well-placed to drive the polyolefin catalysts and components business toward success, the company added.

Shares of Albemarle have rallied 18.1% in the past six months, outperforming the industry’s 13.9% growth.


In November, Albemarle raised its guidance for 2017 and the company now expects full-year net sales of between $3 billion and $3.05 billion (compared with the prior view of $2.90-$3.05 billion), adjusted earnings per share between $4.40 and $4.50 (compared with the prior view of $4.20 and $4.40) and adjusted EBITDA of $860-$875 million (compared with $835-$875 million expected earlier).

Albemarle remains focused on strengthening its lithium business. The company is well placed to leverage strong expected growth in the battery-grade lithium market. Albemarle is executing a number of projects that are likely to boost its global lithium derivative capacity to 165,000 metric tons by 2021.

Additionally, Albemarle’s strategy to sell non-core businesses and assets is likely to boost its growth opportunities and focus on its key businesses.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Rank & Other Stocks to Consider

Albemarle currently carries a Zacks Rank #2 (Buy).

Some other top-ranked stocks in the basic materials space are Westlake Chemical Corporation (NYSE:WLK) , Daqo New Energy Corp. (NYSE:DQ) and Kronos Worldwide Inc. (NYSE:KRO) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Westlake Chemical has an expected long-term earnings growth rate of 10.6%. Its shares have moved up 80.3% year to date.

Daqo New Energy has an expected long-term earnings growth rate of 7%. Its shares have surged a whopping 142.7% year to date.

Kronos Worldwide has an expected long-term earnings growth rate of 5%. Its shares have rallied 109.6% year to date.

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.

Click here to see them >>



Albemarle Corporation (ALB): Free Stock Analysis Report

Kronos Worldwide Inc (KRO): Free Stock Analysis Report

Westlake Chemical Corporation (WLK): Free Stock Analysis Report

DAQO New Energy Corp. (DQ): Free Stock Analysis Report

Original post

Zacks Investment Research
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.